Characterization and Diagnostic Applications of Patient-derived Tumor Organoids

Presented by

Florencia Madorsky Rowdo, Ph.D., Postdoctoral Associate at Englander Institute for Precision Medicine

About this talk

Title: Characterization and Diagnostic Applications of Patient-derived Tumor Organoids 3D CELL CULTURE SUMMIT MASTER SERIES As part of the Englander Institute for Precision Medicine, the Tumor Organoid Platform is an active program focused on development of 3D patient derived tumor organoids (PDTO) from metastatic and primary anatomic sites, obtained through biopsies, surgical resections and rapid autopsy procedures. In this setting, the Tumor Organoid Platform has established a “living biobank” of 160 patient tumor organoids comprising 14 different tumor types. These models are used for High Throughput Drug Screening, the identification of new targets using CRISPR Cas9 Screenings and the generation of co-cultures with different cell types present in the tumor microenvironment, including immune cells and fibroblasts.

Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (151)
Subscribers (17234)
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.